Connecticut Receives $10 Million in Psychiatric Drug Case

, The Connecticut Law Tribune

   |0 Comments

Connecticut is slated to receive over $10 million as part of a multistate national settlement with Johnson & Johnson to resolve allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202626877325

Thank you!

This article's comments will be reviewed.